RxDoctor Payments Data

Archana Nair, MD

Retina Specialist · McKinney, TXNPI 1871027128

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,995 of the $12,769 with a category attached, or 78.3%. AbbVie accounts for 82.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $10,612, more than ten times the $137 reported in 2021.

$12,769in general payments, 2019–2025

Across 45 payments — averaging $283.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$11K
  • Eyepoint US, Inc.$1K
  • Alcon$624
  • Regeneron Healthcare Solutions, Inc.$241
  • Regeneron$117
  • Astellas Pharma US Inc$59
  • plus $139 from 3 others

What the payments were for

  • Consulting fees$9,99578%
  • Travel & lodging$1,0618%
  • Food & beverage$1,71313%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,769 in reported general payments places this provider in the 85th percentile of 108 retina specialist providers in Texas.

See all retina specialist providers in Texas

Medicare billing

Part B allowed, 2024
$632,011
Medicare patients
287
Services billed
6,940

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate75$3,638
MoxifloxacinMoxifloxacin Hcl55$1,249
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat46$672
Brimonidine Tartrate17$242
Ondansetron OdtOndansetron14$95
Promethazine Hcl11$27

Paid to pharmacies, not to this prescriber.

Other retina specialist in McKinney

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →